You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 255 No. 6, February 14, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (73)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Comparison of Loperamide With Bismuth Subsalicylate for the Treatment of Acute Travelers' Diarrhea

Philip C. Johnson, MD; Charles D. Ericsson, MD; Herbert L. DuPont, MD; Donna R. Morgan, PhD; Jo Ann M. Bitsura, MPH; Lindsey V. Wood, PhD

JAMA. 1986;255(6):757-760.


Abstract

Loperamide hydrochloride was compared with bismuth subsalicylate for the treatment of acute nondysenteric travelers' diarrhea in 219 students visiting seven countries in Latin America. Subjects whose condition was not improved with therapy could elect to take trimethoprim-sulfamethoxazole. Persons receiving loperamide passed fewer unformed stools when compared with the bismuth subsalicylate group during the first four hours of therapy, from four to 24 hours, and from 24 to 48 hours after therapy was initiated. Among subjects with disease due to enterotoxigenic Escherichia coli, Shigella sp, other pathogens, and unknown agents, fewer unformed stools were passed by the loperamide-treated subjects than the bismuth subsalicylate-treated subjects for all time periods studied. No significant prolongation of disease was seen in subjects with shigellosis treated with loperamide. Eight of the loperamide-treated subjects experienced constipation compared with one in the bismuth subsalicylate-treated group; otherwise, there was no difference in minor side effects experienced between both treatment groups. We conclude that loperamide is a safe and effective alternative to bismuth subsalicylate for the treatment of nondysenteric travelers' diarrhea.

(JAMA 1986;255:757-760)



Author Affiliations

From the Program in Infectious Diseases and Clinical Microbiology, The University of Texas Health Science Center at Houston.


Footnotes

Reprint requests to The University of Texas Health Science Center, 1728 Freeman Bldg, 6431 Fannin, Houston, TX 77030 (Dr Johnson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of travellers' diarrhoea
Hill and Ryan
BMJ 2008;337:a1746-a1746.
FULL TEXT  

Prevention and Self-Treatment of Traveler's Diarrhea
Diemert
Clin. Microbiol. Rev. 2006;19:583-594.
ABSTRACT | FULL TEXT  

Acute Infectious Diarrhea
Thielman and Guerrant
NEJM 2004;350:38-47.
FULL TEXT  

Prevention and Treatment of Traveler's Diarrhea
DuPont and Ericsson
NEJM 1993;328:1821-1827.
FULL TEXT  

Treatment of Travelers' Diarrhea: Ciprofloxacin plus Loperamide Compared with Ciprofloxacin Alone: A Placebo-Controlled, Randomized Trial
Taylor et al.
ANN INTERN MED 1991;114:731-734.
ABSTRACT  

Treatment of Traveler's Diarrhea With Sulfamethoxazole and Trimethoprim and Loperamide
Ericsson et al.
JAMA 1990;263:257-261.
ABSTRACT  

Etiology of Diarrhea Among Travelers and Foreign Residents in Nepal
Taylor et al.
JAMA 1988;260:1245-1248.
ABSTRACT  

Health Advice for International Travel
HILL and PEARSON
ANN INTERN MED 1988;108:839-852.
ABSTRACT  

Ciprofloxacin or Trimethoprim-Sulfamethoxazole as Initial Therapy for Travelers' Diarrhea: A Placebo-Controlled, Randomized Trial
ERICSSON et al.
ANN INTERN MED 1987;106:216-220.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.